174 related articles for article (PubMed ID: 37064483)
21. Validity of oral fluid test for Delta-9-tetrahydrocannabinol in drivers using the 2013 National Roadside Survey Data.
Jin H; Williams SZ; Chihuri ST; Li G; Chen Q
Inj Epidemiol; 2018 Feb; 5(1):3. PubMed ID: 29457201
[TBL] [Abstract][Full Text] [Related]
22. Occupational Exposure to Secondhand Cannabis Smoke Among Law Enforcement Officers Providing Security at Outdoor Concert Events.
Wiegand DM; Methner MM; Grimes GR; Couch JR; Wang L; Zhang L; Blount BC
Ann Work Expo Health; 2020 Aug; 64(7):705-714. PubMed ID: 32219297
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices.
Desrosiers NA; Milman G; Mendu DR; Lee D; Barnes AJ; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2014 Jul; 406(17):4117-28. PubMed ID: 24828976
[TBL] [Abstract][Full Text] [Related]
24. Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector.
Wille SM; Di Fazio V; Ramírez-Fernandez Mdel M; Kummer N; Samyn N
Ther Drug Monit; 2013 Feb; 35(1):101-11. PubMed ID: 23318281
[TBL] [Abstract][Full Text] [Related]
25. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
[TBL] [Abstract][Full Text] [Related]
26. Determination of cannabinoids in urine, oral fluid and hair samples after repeated intake of CBD-rich cannabis by smoking.
Gerace E; Bakanova SP; Di Corcia D; Salomone A; Vincenti M
Forensic Sci Int; 2021 Jan; 318():110561. PubMed ID: 33172758
[TBL] [Abstract][Full Text] [Related]
27. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
28. Roadside drug testing: comparison of two legal approaches in Belgium.
Van der Linden T; Wille SM; Ramírez-Fernandez M; Verstraete AG; Samyn N
Forensic Sci Int; 2015 Apr; 249():148-55. PubMed ID: 25700110
[TBL] [Abstract][Full Text] [Related]
29. Cannabis and Driving.
Pearlson GD; Stevens MC; D'Souza DC
Front Psychiatry; 2021; 12():689444. PubMed ID: 34630173
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Oral Fluid as a Specimen for DUID.
Veitenheimer AM; Wagner JR
J Anal Toxicol; 2017 Jul; 41(6):517-522. PubMed ID: 28633318
[TBL] [Abstract][Full Text] [Related]
31. Passive cannabis smoke exposure and oral fluid testing.
Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
[TBL] [Abstract][Full Text] [Related]
32. Detection of delta-9-tetrahydrocannabinol (THC) in oral fluid, blood and urine following oral consumption of low-content THC hemp oil.
Hayley AC; Downey LA; Hansen G; Dowell A; Savins D; Buchta R; Catubig R; Houlden R; Stough CKK
Forensic Sci Int; 2018 Mar; 284():101-106. PubMed ID: 29408718
[TBL] [Abstract][Full Text] [Related]
33. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
Huestis MA; Cone EJ
J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of four oral fluid devices (DDS®, Drugtest 5000®, Drugwipe 5+® and RapidSTAT®) for on-site monitoring drugged driving in comparison with UHPLC-MS/MS analysis.
Strano-Rossi S; Castrignanò E; Anzillotti L; Serpelloni G; Mollica R; Tagliaro F; Pascali JP; di Stefano D; Sgalla R; Chiarotti M
Forensic Sci Int; 2012 Sep; 221(1-3):70-6. PubMed ID: 22554872
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes.
Vandrey R; Herrmann ES; Mitchell JM; Bigelow GE; Flegel R; LoDico C; Cone EJ
J Anal Toxicol; 2017 Mar; 41(2):83-99. PubMed ID: 28158482
[TBL] [Abstract][Full Text] [Related]
36. Marijuana use and driving in Washington State: Risk perceptions and behaviors before and after implementation of retail sales.
Eichelberger AH
Traffic Inj Prev; 2019; 20(1):23-29. PubMed ID: 30822133
[TBL] [Abstract][Full Text] [Related]
37. Influence of ethanol on the pharmacokinetic properties of Δ9-tetrahydrocannabinol in oral fluid.
Toennes SW; Schneider K; Wunder C; Kauert GF; Moeller MR; Theunissen EL; Ramaekers JG
J Anal Toxicol; 2013 Apr; 37(3):152-8. PubMed ID: 23429905
[TBL] [Abstract][Full Text] [Related]
38. Drivers who tested positive for cannabis in oral fluid: a longitudinal analysis of administrative data for Spain between 2011 and 2016.
Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Alvarez FJ
BMJ Open; 2019 Aug; 9(8):e026648. PubMed ID: 31455697
[TBL] [Abstract][Full Text] [Related]
39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the Cozart DDSV test for cannabis in oral fluid.
Kintz P; Brunet B; Muller JF; Serra W; Villain M; Cirimele V; Mura P
Ther Drug Monit; 2009 Feb; 31(1):131-4. PubMed ID: 19155965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]